US 9707295
Inhalable medicament
granted A61KA61K31/46A61K47/02
Quick answer
US patent 9707295 (Inhalable medicament) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Branded Pharmaceutical Products R&D, Inc.
- Grant date
- Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/46, A61K47/02, A61K47/06, A61K47/10